FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q2 2025

SEC EDGAR SourceSEC Filings

Top Holdings145 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

5.5M$3.4B14.3%$611.40+26.38%
1 qtr
New
98
HYGHYG
PUT

ISHR IBX USD HIYLD CB ETF-UI

18M$1.5B6.1%
New

MICROSOFT CORP

1.7M$869.4M3.7%$300.17+64.64%
27 qtrssince 2018-Q4
Decreased
0

NATERA INC

4.8M$814.6M3.4%$74.46+125.58%
17 qtrssince 2021-Q2
Increased
62

HESS CORP

5.8M$804.2M3.4%
7 qtrssince 2023-Q4
Increased
62

AON PLC

2M$708.7M3.0%$321.90+10.31%
6 qtrssince 2024-Q1
Increased
74

EXELIXIS INC

16M$706.8M3.0%$19.15+128.03%
27 qtrssince 2018-Q4
Decreased
0

AMAZON.COM INC

3M$665.8M2.8%$223.300.00%
1 qtr
New
82

IQVIA HOLDINGS INC

3.9M$606.9M2.6%$169.89-7.31%
27 qtrssince 2018-Q4
Increased
61

WALT DISNEY CO/THE

4.9M$604.5M2.5%$96.39+26.07%
5 qtrssince 2024-Q2
Decreased
0

SALESFORCE.COM INC

2.1M$575.1M2.4%$230.46+18.24%
23 qtrssince 2019-Q4
Increased
58

THERMO FISHER SCIENTIFIC INC

1.4M$560.8M2.4%$453.07-10.03%
23 qtrssince 2019-Q4
Increased
69

LANTHEUS HOLDINGS INC

6.7M$550.3M2.3%$84.51-3.58%
10 qtrssince 2023-Q1
Increased
60

ARAMARK

12.9M$540.1M2.3%$28.25+46.54%
19 qtrssince 2020-Q4
Decreased
0

AUTODESK INC

1.7M$540.1M2.3%$294.73+3.53%
3 qtrssince 2024-Q4
Decreased
0

REVOLUTION MEDICINES INC

14.3M$527M2.2%$34.81+6.04%
18 qtrssince 2021-Q1
Increased
57

UNITEDHEALTH GROUP INC

1.6M$504.5M2.1%$456.83-33.21%
10 qtrssince 2023-Q1
Increased
58

TRANSUNION

5.4M$475.6M2.0%$85.96+1.23%
27 qtrssince 2018-Q4
Decreased
0
IBITIBIT
ETF

ISHARES BITCOIN TRUST

7M$429.7M1.8%$52.16+16.42%
4 qtrssince 2024-Q3
Increased
59

BOSTON SCIENTIFIC CORP

4M$427.6M1.8%$54.63+96.60%
20 qtrssince 2020-Q3
Increased
52
$23.8B
AUM
145
Positions
Q2 2025
Filing
Rating · 1.5
Quarterly Portfolio Change
+8%Q1'24$23.6B-1%Q2'24$23.3B-2%Q3'24$22.8B-0%Q4'24$22.8B-9%Q1'25$20.9B+14%Q2'25$23.8B
Activity profile
$ moved · Q2'25
New45%Increased17%Decreased9%Exited29%
Composition
Equity vs derivatives
Equity92%Puts8%Calls0%
Holding period
Avg 2.4 years
<1Q9%1-4Q23%1-2Y29%2Y+39%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $23.8B across 145 positions as of Q2 2025. Top holdings: SPY (14.3%), HYG (6.1%), MSFT (3.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.

Q2 2025 Summary

Active quarter - 18 new positions, 19 exits, 38 increased. Top move: SPY (NEW, conviction 98). Portfolio: $23.8B across 145 positions.

Top holdings by portfolio weight

Total AUM$22B
SPY14.28%
MSFT3.65%
NTRA3.42%
HES3.38%
AON2.98%
EXEL2.97%
AMZN2.80%
IQV2.55%
DIS2.54%
CRM2.42%
Other2.36%

Portfolio allocation by GICS sector

Sectors10
Healthcare34.22%
Unknown26.06%
Technology12.56%
Financial Services9.68%
Communication Services7.75%
Industrials4.80%
Consumer Cyclical3.28%
Real Estate1.35%
Consumer Defensive0.29%
Energy0.01%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record60
Conviction43
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q3 2024 Q2 2026+8.5M shares+$314.1M
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 Q2 2026+9M shares+$755.7M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used